A detailed history of Exchange Traded Concepts, LLC transactions in Legend Biotech Corp stock. As of the latest transaction made, Exchange Traded Concepts, LLC holds 3,288 shares of LEGN stock, worth $159,566. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,288
Previous 4,310 23.71%
Holding current value
$159,566
Previous $241,000 39.83%
% of portfolio
0.0%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$39.5 - $57.22 $40,369 - $58,478
-1,022 Reduced 23.71%
3,288 $145,000
Q1 2024

Apr 15, 2024

BUY
$55.06 - $69.99 $120,966 - $153,768
2,197 Added 103.98%
4,310 $241,000
Q4 2023

Jan 05, 2024

SELL
$57.25 - $69.74 $74,711 - $91,010
-1,305 Reduced 38.18%
2,113 $127,000
Q3 2023

Oct 18, 2023

SELL
$63.16 - $76.5 $28,485 - $34,501
-451 Reduced 11.66%
3,418 $229,000
Q2 2023

Jul 20, 2023

BUY
$46.28 - $75.01 $179,057 - $290,213
3,869 New
3,869 $267,000

Others Institutions Holding LEGN

About Legend Biotech Corp


  • Ticker LEGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 167,403,008
  • Market Cap $8.12B
  • Description
  • Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...
More about LEGN
Track This Portfolio

Track Exchange Traded Concepts, LLC Portfolio

Follow Exchange Traded Concepts, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exchange Traded Concepts, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Exchange Traded Concepts, LLC with notifications on news.